Company Profile (AI Text)
Name: Element Apothec
Canonical URL: https://wefunder.com/element.apothec
Updated at: 2026-06-12T05:00:19Z

Tagline: Socially motivated and purpose-driven CBD brand positively impacting the lives of our customers 
Elevator pitch: Element Apothec develops, formulates, and sells all-natural, plant-based body care and wellness products infused with beneficial phytocannabinoids.

Key claims:
- Total raised on Wefunder: 119044 | citation: https://wefunder.com/element.apothec#claim-total-raised
- Total investors: 122 | citation: https://wefunder.com/element.apothec#claim-total-investors

Verified facts:
- Total raised on Wefunder: 119044 | observed_at: 2026-06-12T05:00:19Z | expires_at: 2026-06-13T05:00:19Z
- Total investors: 122 | observed_at: 2026-06-12T05:00:19Z | expires_at: 2026-06-13T05:00:19Z

Computed metrics:
- total_amount_raised: 119044
- total_investors: 122
- team_size: 10
- featured_investor_count: 1
- faq_count: 5
- recent_post_count: 0

Quick facts:
- Poised to be a market leader by competitively differentiating ourselves to become a trusted brand in an expanding market | citation: https://wefunder.com/element.apothec#claim-fact-1
- HUGE upside opportunity - the CBD market is expected to expand to over $16 billion by 2025 | citation: https://wefunder.com/element.apothec#claim-fact-2
- Quality Wins - clean, safe, highly effective, 3rd party tested, market-leading products with THC-free CBD, CBG, and CBN | citation: https://wefunder.com/element.apothec#claim-fact-3
- Co-founded with a highly-regarded integrative pharmacist - along with a team of respected medical advisors | citation: https://wefunder.com/element.apothec#claim-fact-4
- Pending B Corp focused on ESG - Ethical Decision Making, Sustainability Pledge, 1% for the planet, radical transparency | citation: https://wefunder.com/element.apothec#claim-fact-5
- Secured distribution through multiple online marketplaces, GPO Medical Group and retail locations | citation: https://wefunder.com/element.apothec#claim-fact-6
- Team and Advisory Board with more than 100 years in CPG, e-comm, healthcare, life sciences & cannabis | citation: https://wefunder.com/element.apothec#claim-fact-7
- Unmatched focus on education with a proprietary education platform and content creation. | citation: https://wefunder.com/element.apothec#claim-fact-8

FAQ:
- Q: Do you intend to pay dividends (post conversion)?
  A: Yes, we intend to give cash dividends post conversion.  We believe in giving back to those that invested in us from the beginning. Our investors should share in our success!
- Q: Will you be going ipo later on?
  A: If, in the future, an IPO makes sense for the company we will certainly consider it. We believe a strategic acquisition would possibly be a likely scenario as well.
- Q: As a new investor, what changes when you go public? How would you rate your company against cbdMD?
  A: Hi Ken, As a new investor if/when we go public your private shares would convert to publicly traded shares. At this time we have not finalized this as an exit strategy and would also consider a Merger or Acquisition as an exit option. In terms of how we rate ourselves against a company such as cbdMD, we are passionate about creating the safest products and will never use any questionable or any of the 1,400 banned ingredients in Canada or Europe in any of the products we create. Unlike many c...
- Q: Hello, I have some questions please help clarify. - You mentioned 30% of the funding will be used for marketing, is there any reason for this as this is a huge percentage of the raise. - Assuming the minimum target was meant, the 50% marked for product development how many dif...
  A: Hello Gboyega. Thank you for the questions. Here are our answers... - The proposed use of funds for marketing is set high because, as a new company, we need to come out of the gate with a strong marketing message to create brand awareness and differentiation in a competitive space. We feel a high marketing budget will set us up for early and future success. - 50% of the funds will be used in the manufacturing of our first set of 10 SKUs to meet our pre-sale demands, early retail commitments a...
- Q: Thank you David for your answers.
  A: You're very welcome!